Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00000194

Neurobiology of Opioid Dependence: 3 - 3

Neurobiology of Opioid Dependence: 3

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Yale University · Academic / Other
Sex
Male
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to study the effects of cycloserine on naloxone-precipitated opiate withdrawal.

Conditions

Interventions

TypeNameDescription
DRUGCycloserine

Timeline

Start date
1993-01-01
Primary completion
1998-01-01
Completion
1998-01-01
First posted
1999-09-21
Last updated
2016-05-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000194. Inclusion in this directory is not an endorsement.